Saul Centers BFS Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | 12.4%-4.7pp | 12.9%-5.9pp | 13.8%-7.0pp | 15.5%-5.0pp | 17.1%-3.2pp | |
| Free cash flow margin | 33.6%-5.8pp | 30.6%-6.6pp | 35.6%+0.2pp | 42.6%+17.3pp | 39.4%+9.1pp | |
| Returns | ||||||
| Return on equity | 11.7%-2.2pp | 11.7%-3.1pp | 11.9%-3.3pp | 12.9%-1.7pp | 13.9%-0.3pp | |
| Return on assets | 1.7%-0.5pp | 1.7%-0.7pp | 1.8%-0.9pp | 2%-0.7pp | 2.2%-0.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 5.3×+0.6× | 0×0.0× | 5×+0.6× | 4.9×+0.7× | 4.7×+0.6× | |
| Debt-to-assets | 0.7×0.0× | 0×0.0× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | |
| Valuation | ||||||
| Market capitalization | $909.54M+8.7% | $769.72M-17.9% | $776.57M-23.3% | $844.64M-4.2% | $872.92M-5.4% | |
| Enterprise value | $2.5B+5.1% | $761.98M-18.0% | $2.35B-5.9% | $2.41B+3.7% | $2.41B+3.7% | |
| Price / earnings | 24.7×+6.8× | 20.5×+2.0× | 19.9×+1.7× | 19.6×+3.3× | 18.6×+1.2× | |
| Price / sales | 3.1×0.0× | 2.7×-0.8× | 2.7×-1.0× | 3×-0.3× | 3.2×-0.4× | |
| Price / book | 3×+0.5× | 2.5×-0.3× | 2.5×-0.5× | 2.6×+0.1× | 2.7×0.0× | |
| EV / sales | 8.4×-0.2× | 2.6×-0.8× | 8.3×-1.0× | 8.7×-0.1× | 8.8×-0.1× | |
| Free cash flow yield | 11%-2.0pp | 11.5%+0.9pp | 13%+3.6pp | 14%+6.4pp | 12.4%+3.8pp | |
| Earnings yield | 4%-1.5pp | 4.9%-0.5pp | 5%-0.5pp | 5.1%-1.0pp | 5.4%-0.4pp | |
| Dividend yield | 6.3%-0.5pp | 7.4%+1.4pp | 7.4%+1.7pp | 6.8%+0.3pp | 6.5%+0.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Saul Centers's ratios come from?
- Every ratio is computed from Saul Centers's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
